Cyclin E and Ki67 (MIB1) as markers of proliferative activity in human prostate cancers - an immunohistochemical study

By Gyftopoulos K.   Perimenis P.   Ravazoula P.   Barbalias G.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 6, 2001-11 ,pp. : 249-253

Elsevier

Access to resources Recommend Favorite

Expression of Ki-67 in Vulvar Carcinoma and Vulvar Intraepithelial Neoplasia III: Correlation with Clinical Prognostic Factors

By Modesitt S.C.   Groben P.A.   Walton L.A.   Fowler W.C.   Van Le L.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 51-55

Elsevier

Access to resources Recommend Favorite

Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma

By Chan J.Y.H.   Meng C.L.   To K.F.   Leung S.F.   Chan A.T.C.   Lee K.K.H.   Johnson P.J.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1600-1606

Elsevier

Access to resources Recommend Favorite

Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer

By Assersohn L.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-01 ,pp. : 113-123

Springer Publishing Company

Access to resources Recommend Favorite

Superficial Bladder Cancer: Study of the Proliferative Nuclear Fraction as a Prognostic Factor

By Blasco-Olaetxea E.   Belloso L.   Garcia-Tamayo J.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 444-446

Elsevier

Access to resources Recommend Favorite